NPS

International Conference on Novel Psychoactive Substances

Abu Dhabi,

The International Conference on Novel Psychoactive Substances series, which started in Budapest in 2012, aims to share knowledge and strengthen collaboration on NPS among multidisciplinary professionals at the international level. To benefit society and improve lives.

Legal responses to novel psychoactive substances implemented by ten European countries: An analysis from legal epidemiology

Citation
Neicun, J., Roman-Urrestarazu, A., & Czabanowska, K. (2022). Legal responses to novel psychoactive substances implemented by ten European countries: an analysis from legal epidemiology. Emerging trends in drugs, addictions, and health, 2, 100044.
Publication Date

Abstract

Introduction

Novel psychoactive substances (NPS) continue to pose challenges to law enforcement authorities, public health officers and policymakers as suppliers continuously adapt to control measures, thus remaining highly dynamic in introducing unpredictable and potentially toxic new substances into the drug market.

Another Milestone for Kenya: Launch of the National Standard on Management of Persons with Substance Use Disorders

According to the International Standards for the Treatment of Drug Use Disorders (2020), the use of psychoactive drugs or narcotic drugs and psychotropic substances without medical supervision is associated with significant health risks. Backing this up the World Drug Report 2022 indicates that around 284 million people aged 15-64 used drugs worldwide in 2022, a 26 percent increase over the previous decade. Unfortunately, this translates to an accelerated impact on public health, drug use disorders